Brief: Neurotech International Seeks Trading Halt
15/04/2024 02:28
April 15 (Reuters) - Neurotech International Ltd
NTI.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL
RAISING.
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON0 PHASE II/III
CLINICAL TRIAL RESULTS IN PAEDIATRIC PATIENTS WITH AUTISM
DISORDER
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON TOP-LINE
RESULTS FOR
PHASE I/II RETT SYNDROME CLINICAL TRIAL
Further company coverage: NTI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt